Process for the preparation of 1,5-disubstituted-3-amino-1,2,4,-triazoles and substituted aminoguanidines as intermediate compounds
申请人:——
公开号:US20040039203A1
公开(公告)日:2004-02-26
New process for the preparation of 1,5-disubstituted-3-amino-1,2,4-triazoles of the general formula (I), wherein the meaning of R is C
1-5
alkyl group; C
3-13
cycloalkyl-C
0-4
alkyl group, optionally substituted by one or more C
1-3
alkyl group; phenyl-C
0-2
alkyl-, (CH
2
)
n
-morpholino-, piperidino-, pyrrolidino- or piperazino-group, optionally substituted by one or more halogen atom, C
1-3
alkyl group, C
1-3
alkoxy group, n is 1-5, R
1
, R
2
, R
3
, and R
4
stand independently for hydrogen, halogen, C
1-6
alkyl group, C
1-3
alkoxy group or trifuluoromethyl group, with the proviso that of the substituents R
1
, R
2
, R
3
, and R
4
at least one stands for hydrogen.
TRIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
申请人:SANOFI-SYNTHELABO
公开号:EP1335914A1
公开(公告)日:2003-08-20
PROCESS FOR THE PREPARATION OF 1,5-DISUBSTITUATED-3-AMINO-1,2,4-TRIAZOLES AND SUBSTITUTED AMINOGUANIDINES AS INTERMEDIATE COMPOUNDS
申请人:SANOFI-SYNTHELABO
公开号:EP1337519A1
公开(公告)日:2003-08-27
[EN] TRIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM<br/>[FR] DERIVES DE TRIAZOLE ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT
申请人:SANOFI SYNTHELABO
公开号:WO2002034743A1
公开(公告)日:2002-05-02
The present invention relates to compounds of formula (I) and their pharmaceutically acceptable salts, solvates, hydrates and polymorphs. These compounds are powerful and selective CCK1 receptor agonists.
[EN] PROCESS FOR THE PREPARATION OF 1,5-DISUBSTITUTED-3-AMINO-1,2,4-TRIAZOLES AND SUBSTITUTED AMINOGUANIDINES AS INTERMEDIATE COMPOUNDS<br/>[FR] PROCEDE DE PREPARATION DE 3-AMINO-1,2,4-TRIAZOLES DISUBSTITUES EN 1,5 ET AMINOGUANIDINES SUBSTITUEES EN TANT QUE COMPOSES INTERMEDIAIRES
申请人:SANOFI SYNTHELABO
公开号:WO2002034729A1
公开(公告)日:2002-05-02
New process for the preparation of 1,5-disubstituted-3-amino-1,2,4-triazoles of the general formula (I), wherein the meaning of R is C1-5alkyl group; C3-13cycloalkyl-C0-4alkyl group, optionally substituted by one or more C1-3alkyl group; phenyl-C0-2alkyl-, (CH2)n-morpholino-, piperidino-, pyrrolidino- or piperazino-group, optionally substituted by one or more halogen atom, C1-3alkyl group, C1-3alkoxy group, n is 1-5, R?1, R2, R3, and R4¿ stand independently for hydrogen, halogen, C¿1-6?alkyl group, C1-3alkoxy group or trifuluoromethyl group, with the proviso that of the substituents R?1, R2, R3, and R4¿ at least one stands for hydrogen.